Characterization of Fatty Acid Profiles in Infants With Intestinal Failure-Associated Liver Disease

Meredith A Baker1, Paul D Mitchell2, Alison A O'Loughlin1

  • 1Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.

Insights

Reduced soybean oil (SO) doses in parenteral nutrition for infants with liver disease altered fatty acid profiles but did not cause essential fatty acid deficiency. These findings impact infant nutrition and liver disease management.

Area of Science:

  • Pediatric Gastroenterology
  • Nutritional Science
  • Neonatology

Background:

  • Infants with intestinal failure-associated liver disease (IFALD) often require parenteral nutrition (PN).
  • Soybean oil-based lipid emulsions (SO) are commonly used in PN but can affect fatty acid profiles (FAPs).
  • Understanding FAPs is crucial for managing IFALD in PN-dependent infants.

Purpose of the Study:

  • To characterize fatty acid profiles (FAPs) in PN-dependent infants with IFALD.
  • To compare FAPs in infants receiving standard doses (SO-S) versus reduced doses (SO-R) of soybean oil-based lipid emulsions.
  • To assess the impact of different SO doses on essential fatty acid deficiency (EFAD) in this population.

Main Methods:

  • Retrospective review of prospectively collected data from infants (<1 year old) with IFALD receiving PN with SO.
  • Analysis of serum fatty acid profiles before transitioning to fish oil-based lipid emulsion.
  • Comparison of demographics, anthropometrics, SO dose, duration of SO use, and FAPs between SO-S and SO-R groups.

Main Results:

  • No demographic or anthropometric differences between SO-S (n=14) and SO-R (n=35) groups.
  • SO-R group showed significantly higher Mead acid and lower levels of α-linolenic, eicosapentaenoic, linoleic, stearic, total ω-3, and total ω-6 fatty acids compared to SO-S group (P < .01).
  • Higher triene:tetraene ratios in the SO-R group (P = .0009), with no patients experiencing biochemical EFAD.

Conclusions:

  • Reduced soybean oil doses in PN for infants with IFALD result in distinct fatty acid profiles compared to standard doses.
  • No infants in either the standard or reduced SO dose group exhibited biochemical essential fatty acid deficiency.
  • These findings suggest careful monitoring of FAPs is warranted when adjusting SO dosage in PN for IFALD.
Abstract

Related Concept Videos

Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.2K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
87.9K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
210
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
713
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
328